Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Pagibaximab, a chimeric IgG1 antibody, targets the lipoteichoic acid on the surfaces of S. aureus and S. epidermidis, and is utilized for the prevention of staphylococcal sepsis [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry |
Description | Pagibaximab, a chimeric IgG1 antibody, targets the lipoteichoic acid on the surfaces of S. aureus and S. epidermidis, and is utilized for the prevention of staphylococcal sepsis [1]. |
Molecular Weight | 146.07 (kDa) |
CAS No. | 595566-61-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Pagibaximab 595566-61-3 inhibitor inhibit